Does active surveillance lead to anxiety and stress?

British Journal of Nursing

Volumn 23, Issue , 2014, Pages S4-S12

  Simpson, Paula ^a  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

Anxiety; Disease progression; Prostate specific antigen; Prostatectomy; Watchful waiting

Indexed keywords

EID: 84908622989     PISSN: 09660461     EISSN: None     Source Type: Journal    
DOI: 10.12968/bjon.2014.23.Sup18.S4     Document Type: Article

References (51)

1. Abouassaly R, Lane BR, Jones JS (2008) Staging saturation biopsy in patients with prostate cancer on active surveillance protocol. Urology 71(4): 573-7 doi:10.1016/j.urology.2007.11.094
2. Bangma CH, Bul M, van der Kwast TH et al (2013) Active surveillance for low-risk prostate cancer. Crit Rev Oncol Haematol 85(3): 295-302
3. Berglund RK, Jones JS (2012) Optimal Prostate Biopsy Regimen. Curr Urol Rep 13(6): 455-9. doi: 10.1007/s11934-012-0285-6
4. Beynon M (2000) Anatomy and Physiology of the Urinary Tract. In: Fillingham S, Douglas J, ed. Urological Nursing. Harcourt, Edinburgh: 25-27
5. Chan JM, Weinberg V, Magbanua MJ et al (2011) Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control 22(1): 141-150
6. Choo R, Klotz L, Danjoux C et al (2002) Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 167(4): 1664-9
7. Dall'Era MA, Albertsen PC, Bangma C et al (2012) Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 62(6): 976-983. doi: 10.1016/j.eururo.2012.05.072
8. Dall'Era MA, Cooperberg MR, Chan JM et al (2008) Active surveillance for early-stage prostate cancer: review of the current literature. Cancer 112(8): 1650-9. doi: 10.1002/cncr.23373
9. Daubenmier JJ, Weidner G, Marlin R et al (2006) Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology 67(1): 125-30
10. Davison BJ, Breckon E (2012) Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns 87(3): 369-374. doi: 10.1016/j.pec.2011.11.009
11. Davison BJ, Oliffe JL, Pickles T, Mroz L (2009) Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum 36(1): 89-96. doi: 10.1188/09.ONF.89-96
12. Davison BJ, Goldenberg SL (2011) Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer. BJU Int 108(11): 1787-93 doi:10.1111/j.1464-410X.2011.10200
13. Dunn MW, Kazer MW (2011) Prostate cancer overview. Semin Oncol Nurs 27(4): 241-50. doi: 10.1016/j.soncn.2011.07.002
14. Eifler JB (2013) Prostate cancer screening and diagnosis. In: Kellogg Parsons J, Eifler JB, Han M, eds. Handbook of Urology. Wiley Blackwell, Chichester: 129-135
15. Gorin MA, Soloway CT, Eldefrawy A, Soloway MS (2011) Factors that influence patient enrollment in active surveillance for Llow-risk prostate cancer. Urology 77(3): 588-91. doi: 10.1016/j.urology.2010.10.039
16. Harlan SR, Cooperberg MR, Elkin E et al (2003) Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE. J Urol 170(5): 1804-7
17. Hart SL, Latini DM, Cowan JE, Carroll PR, CaPSURE Investigators (2008) Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer 16(2): 161-9
18. Hegarty J, Bailey DE Jr (2011) Active surveillance as a treatment option for prostate cancer. Semin Ocol Nurs 27(4): 260-6. doi:10.1016/j.soncn.2011.07.004
19. Iczkowski KA, Lucia MS (2011) Current perspectives on Gleason grading of prostate cancer. Curr Urol Rep 12(3): 216-22. doi: 10.1007/s11934-011-0181-5
20. Iremashvili V, Pelaez L, Manoharan M, Jorda M, Rosenberg DL, Soloway MS (2012) Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols. Eur Urol 6(3): 462-8. doi: 10.1016/j.eururo.2012.03.011
21. Kazer MW, Bailey DE Jr, Colberg J, Kelly WK, Carroll P (2011a) The needs for men undergoing active surveillance (AS) for prostate cancer: results of a focus group study. J Clin Nurs 20(3-4): 581-6. doi: 10.1111/j.1365-2702.2010.03489.x
22. Kazer MW, Bailey DE Jr, Donald E, Sanda M, Colberg J, Kelly WK (2011b) An Internet intervention for management of uncertainty during active surveillance for prostate cancer. Oncol Nurs Forum 38(5): 561-8.
23. Klotz L (2013) Active Surveillance for prostate cancer: overview and update. Curr Treat Options Oncol 14(1): 97-108. doi: 10.1007/s11864-012-0221-5
24. Lintz K, Moynihan C, Steginga S et al (2003) Prostate cancer patients' support and psychological care needs: Survey from a non-surgical oncology clinic. Psychooncology 12(8): 769-83
25. The Lancet (editorial) (2014) Active surveillance for early-stage prostate cancer. Lancet 383(9913): 188
26. Lynch, T (2012) Telephone helpline supports patients with prostate cancer. Cancer Nursing Practice 11(3): 30-34 http://dx.doi.org/10.7748/cnp2012.04.11.3.30.c9037
27. McCartney M (2013) The perils of overdiagnosis. Trends in Urology and Men's Health 4(2): 19-21. doi: 10.1002/tre.320
28. Magbanua MJ, Richman EL, Sosa EV et al (2014) Physical activity and prostate gene expression in men with low-risk prostate cancer. Cancer Causes Control 25(4): 515-23. doi: 10.1007/s10552-014-0354-x
29. Mann L, Ford A (2012) A tool to measure levels of psychological distress. Nursingtimes.net. http://tinyurl.com/npdfq5f (accessed 22 September 2014)
30. Mishel MH (1988) Uncertainty in Illness. Journal of Nursing Scholarship 20(4): 225-32. doi: 10.1111/j.1547-5069.1988.tb00082.x
31. Morrison V, Bennett P (2012) An introduction to health psychology 3rd ed. Pearson/Prentice Hall, Harlow.
32. National Institute of Clinical Excellence (2014) Prostate Cancer: diagnosis and treatment NICE clinical guidelines CG175 s.l.: NICE.
33. Ogden J (2012) Health Psychology: A Textbook. Fifth Ed. Maidenhead: Open University Press
34. Olife J L, Davison B J, Pickles T (2009) The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer. Qualitative health research 19(4): 432-443
35. Parker C (2004) Active surveillance of early prostate cancer: rational, initial results and future developments. Prostate cancer and prostate diseases 7(3): 178-181
36. Peate I (2003) Men's Sexual Health. First ed. London: Whurr Publishers Ltd.
37. Pickles T, Dean Ruether J, Weir L, Carlson L, Jakulj F, SCRN Communication Team (2007) Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. British Journal of Urology International 100(3): 544-551
38. Prostate Cancer Charity (2011) Making Connections. Annual Review 2010/11. Prostate Cancer Charity, London
39. Prostate Cancer UK(2014) Prostate cancer facts and figures (online) Last accessed 29th March 2014 at: http://prostatecanceruk.org/information/prostate-cancer-facts-and-figures
40. Rothwax J T, George A K, Wood B J, & Pinto P A (2014) Multiparametric MRI in Biopsy Guidance for Prostate Cancer: Fusion-guided. BioMed Research International 2014: 1-7.
41. Sartor O (2008) Counselling of the Prostate Cancer Patient. European Urology Supplements 7(13): 765-771
42. Seiler D, Randazzo M, Leupold U et al (2012) Protocol-based active surveillance for low- risk prostate cancer: anxiety levels in both men and their partners. Urology 80 (3): 564-569
43. Shaida C, Jones C, Ravindranath N, Das T, Wilmott K, Jones A et al (2007) Patient satisfaction with nurse led telephone consultation for the follow-up of patients with prostate cancer. Prostate cancer and Prostatic Diseases 10(4): 369-373
44. Soloway M S, Soloway C T, Eldefrawy A, Acosta K, Kava B, Manoharan M (2010) Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. European Urology 58(6): 831-835
45. Snowden A, White C A, Christie Z, Murray E, McGowan C, Scott R (2011) The clinical utility of the Distress Thermometer: a review. British Journal of Nursing 20 (4): 220 - 227
46. van den Bergh R C, Roemeling S, Roobol M J, Gunnar A, Hugosson J, Rannikko A S et al (2009a) Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. European Urology 55 (1): 1-8
47. van den Bergh R C, Essink-Bot M L, Roobol M J, Wolters T, Fritz H, Scroeder M D et al (2009b) Anxiety and Distress During Active Surveillance for Early Prostate Cancer. Cancer 15 (17): 3868-3878
48. Vasarainen H, Lokman U, Ruutu, M, Taari K, Rannikko A (2012) Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. British Journal Urology International 109 (11): 1614-1619
49. Venderbos L D F, Roobol M J (2011) PSA-based prostate cancer screening: the role of active surveillance and informed and shared decision making. Asian Journal of Andrology 13 (2): 219-224
50. Wallace M, Storm S (2007) The needs of men with prostate cancer: results of a focus group study.. Applied Nursing Research 20(4): 181-187
51. Wilcox C B, Gilbound D, Louie-Johnsun M (2014) Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre. British Journal Urology International 113 (S2): 64-68